Literature DB >> 18241883

Assessment of haemic neoplasia in different soft shell clam Mya arenaria populations from eastern Canada by flow cytometry.

Maryse Delaporte1, Stéphanie Synard, Julie Pariseau, Patricia McKenna, Réjean Tremblay, Jeffery Davidson, Franck C J Berthe.   

Abstract

Diagnosis of haemic neoplasia (HN) in the soft shell clam, Mya arenaria, is often achieved by hematocytology and histology. Since neoplastic cells display tetraploid DNA contents, haemocyte cell cycle analysis was developed for use as a diagnosis tool. The aim of this study was to assess the application of a flow cytometry procedure of cell cycle analysis established for the common cockle, to clams and to evaluate different thresholds of value for the percentage of tetraploid cells for establishing HN disease status of individual clams and clam populations. HN status of six clam populations from eastern Canada was determined. Results of the present study demonstrate a flow cytometry procedure to be useful for HN diagnosis in clams. Individual clams were considered to be affected by HN when presenting at least 20% of haemocytes in S-4N phase; and negative when presenting less that 5% of haemocytes in S-4N phase. As discussed in this paper, intermediate cases represent uncertain diagnoses including either false-negative or false-positive clams, which are difficult to discriminate. At a population level, an additional threshold of 15% for the mean intensity of the disease is proposed, which means having in the population several individual clams presenting more than 20% of their haemocytes in S-4N phase. Based on these thresholds of value, only one population was considered as free of HN disease, and one population was unequivocally affected by HN. For the four other clam populations, further investigations are needed toward development and use of specific and objective biomarkers of HN.

Entities:  

Mesh:

Year:  2007        PMID: 18241883     DOI: 10.1016/j.jip.2007.12.005

Source DB:  PubMed          Journal:  J Invertebr Pathol        ISSN: 0022-2011            Impact factor:   2.841


  7 in total

1.  Expression of RAS-like family members, c-jun and c-myc mRNA levels in neoplastic hemocytes of soft-shell clams Mya arenaria using microsphere-based 8-plex branched DNA assay.

Authors:  A Siah; P McKenna; J M Danger; G Johnson; F C J Berthe
Journal:  Results Immunol       Date:  2012-04-07

2.  Transcriptome analysis of neoplastic hemocytes in soft-shell clams Mya arenaria: Focus on cell cycle molecular mechanism.

Authors:  Ahmed Siah; Patty McKenna; Franck C J Berthe; Luis O B Afonso; Jean-Michel Danger
Journal:  Results Immunol       Date:  2013-11-01

3.  Effects of pesticide compounds (chlorothalonil and mancozeb) and benzo[a]pyrene mixture on aryl hydrocarbon receptor, p53 and ubiquitin gene expression levels in haemocytes of soft-shell clams (Mya arenaria).

Authors:  Julie Pariseau; Patricia McKenna; Mohammed Aboelkhair; Richard Saint-Louis; Emilien Pelletier; T Jeffrey Davidson; Réjean Tremblay; Franck C J Berthe; Ahmed Siah
Journal:  Ecotoxicology       Date:  2011-06-18       Impact factor: 2.823

4.  Disseminated neoplasia in the soft-shell clam Mya arenaria: membrane lipid composition and functional parameters of circulating cells.

Authors:  Fabienne Le Grand; Philippe Soudant; Ahmed Siah; Réjean Tremblay; Yanic Marty; Edouard Kraffe
Journal:  Lipids       Date:  2014-06-17       Impact factor: 1.880

5.  Molluscan cells in culture: primary cell cultures and cell lines.

Authors:  T P Yoshino; U Bickham; C J Bayne
Journal:  Can J Zool       Date:  2013-06-01       Impact factor: 1.597

6.  Horizontal transmission of clonal cancer cells causes leukemia in soft-shell clams.

Authors:  Michael J Metzger; Carol Reinisch; James Sherry; Stephen P Goff
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

7.  Nuclear morphometry and ploidy of normal and neoplastic haemocytes in mussels.

Authors:  Francesca Carella; Gionata De Vico; Gabriel Landini
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.